Trials / Completed
CompletedNCT00998829
Study Evaluating The Prevalence Of Undiagnosed Psoriatic Arthritis In Patients With Plaque Psoriasis
An Australian Cross-Sectional Epidemiological Study To Evaluate The Prevalence Of Undiagnosed Psoriatic Arthritis In Psoriasis Patients In Dermatology Practice Focusing On Disease Severity, Disease Burden And Quality Of Life
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 458 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to collect Australian data on the prevalence of undiagnosed psoriatic arthritis in patients with plaque psoriasis. In addition the study will assess disease severity and quality of life in Australian patients with psoriasis attending specialist dermatology clinics.
Detailed description
Consecutive psoriasis patients seen at each site will be invited to participate in the study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | questionnaire | There is no therapeutic intervention in this study. However PASE (Psoriatic Arthritis Screening and Evaluation) and other patient questionnaires will be completed by participants. |
Timeline
- Start date
- 2010-05-01
- Primary completion
- 2012-05-01
- Completion
- 2012-05-01
- First posted
- 2009-10-21
- Last updated
- 2012-11-29
Locations
9 sites across 1 country: Australia
Source: ClinicalTrials.gov record NCT00998829. Inclusion in this directory is not an endorsement.